The 4th ESCP Masterclass was successfully held on 27 August 2025 in Cairo, Egypt, drawing an impressive attendance of 132 participants, including leading international experts, regional surgeons, and trainees.
September's Paper of the Month looks at a double-blind, randomised, placebo-controlled trial involving patients with stage I, II, or III rectal cancer or stage II or III colon cancer with somatic alterations in PI3K pathway genes.
This month's paper assessed the noninferior results of chemoradiotherapy and local excision compared with Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer.